GHB
- GHB is a Schedule I substance in the U.S., meaning it has a high potential for abuse, has no currently accepted medical use, and lacks safe-use guidelines. This is the most restricted drug schedule.
- In 1998, GHB led to 1,343 emergency room visits.
- The DEA reports that since 1992, there have been over 3500 overdoses on GHB.
Rohypnol
- Rohypnol (the brand name for flunitrazepam) is a Schedule IV substance in the U.S., meaning that it has a currently accepted medical use, but may lead to physical dependence and psychological dependence.
- Rohypnol is 10 times as strong as the common sedative Valium.
- A recent congressional study showed that in one year, over 4 million doses of Rohypnol were brought into the United States from Mexico.
Ketamine
- In August 1999, the U.S. DEA made Ketamine a Schedule III drug, meaning that while it has a currently accepted medical use in the U.S., it has a high likelihood of leading to psychological dependence and some likelihood of leading to physical dependence.
- Since 1992 DEA has received more than 500 reports of the sale and/or use of the drug in schools by minors, on college campuses, at nightclubs and rave dances.
- The Drug Abuse Warning Network (DAWN) recorded 207 Ketamine related hospital emergency room episodes between 1993 and 1998.
Rape
- Approximately 1,872 women are sexually assaulted in the United States every day.
- 1 in 3 women will be sexually assaulted in their lifetime.
- 1 in 5 men will be assaulted in their lifetime.
- 1 in 8 college women have been victims of rape.
- 1 in 12 college men admitted to sexually abusing women but did not consider themselves rapists.
- Nationally, 85% of all sexual assaults are committed by someone known to the victim.
- 47% of rapes were by first or casual dates or by romantic acquaintances
